EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mesenchymal Stem Cell Therapy Modulates Peripheral–Central Immune Interactions and Attenuates Neuroinflammation-Driven Cognitive Dysfunction

Gunel Ayyubova, Shahla Huseynova, Nigar Mustafayeva, Leyla Yildirim, Seher Ismayilova, Tarana Gasimova, Sabina Aliyeva

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27031182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Gunel Ayyubova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cytology, Embryology and Histology, Azerbaijan Medical University, Baku AZ1022, Azerbaijan. Hauptthemen laut MEDLINE: Mesenchymal Stem Cell Transplantation, Neuroinflammatory Diseases, Cognitive Dysfunction, Mesenchymal Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peripheral inflammation is increasingly recognized as a critical driver of sustained neuroinflammation and cognitive dysfunction in neurodegenerative and inflammation-associated disorders. Systemic inflammatory mediators can compromise blood–brain barrier integrity, activate glial cells, and initiate maladaptive neuroimmune cascades that disrupt hippocampal–prefrontal circuits underlying learning and memory. Here, we investigated whether early systemic administration of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) mitigates inflammation-driven cognitive deficits in a chronic lipopolysaccharide (LPS) mouse model. Adult mice received daily LPS injections for seven days to induce persistent systemic and central inflammation, which was confirmed by serum and hippocampal cytokine analyses in a separate cohort at the time of MSC administration, followed by intravenous MSC treatment immediately after cessation of the inflammatory insult. Behavioral testing revealed significant impairments in spatial working memory, recognition memory, and associative learning. These deficits were accompanied by pronounced microglial activation, immune cell accumulation, astrocytosis, and a shift toward a pro-inflammatory cytokine milieu with suppression of IL-10 in the hippocampal CA1 region and medial prefrontal cortex. Early MSC treatment attenuated glial reactivity, reduced pro-inflammatory cytokines, restored IL-10 expression, and partially rescued cognitive performance. Collectively, these findings identify a post-inflammatory therapeutic window in which early MSC-based immunomodulation can rebalance neuroimmune signaling and limit inflammation-induced hippocampal–prefrontal circuit dysfunction, highlighting a clinically relevant strategy for targeting cognitive impairment associated with chronic systemic inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem Cell TransplantationNeuroinflammatory DiseasesCognitive DysfunctionMesenchymal Stem CellsAnimalsMiceLipopolysaccharidesMaleCytokinesHumansInflammationDisease Models, AnimalHippocampusMicrogliaMice, Inbred C57BL

Stichwörter der Autor:innen

cognitive dysfunctioncytokineslipopolysaccharidemesenchymal stem cellsmicroglianeuroinflammation

Substanzen

LipopolysaccharidesCytokines

Autor:innen und Institutionen

  • Department of Cytology, Embryology and Histology, Azerbaijan Medical University, Baku AZ1022, Azerbaijan.
  • Department of Human Anatomy and Medical Terminology, Azerbaijan Medical University, Baku AZ1022, Azerbaijan.
  • Genetic Resources Institute of the Azerbaijan National Academy of Sciences, Baku AZ1143, Azerbaijan.

Zitieren

APA

Ayyubova, G., Huseynova, S., Mustafayeva, N., Yildirim, L., Ismayilova, S., Gasimova, T., & Aliyeva, S. (2026). Mesenchymal Stem Cell Therapy Modulates Peripheral–Central Immune Interactions and Attenuates Neuroinflammation-Driven Cognitive Dysfunction. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031182

Vancouver

Ayyubova G, Huseynova S, Mustafayeva N, Yildirim L, Ismayilova S, Gasimova T, et al. Mesenchymal Stem Cell Therapy Modulates Peripheral–Central Immune Interactions and Attenuates Neuroinflammation-Driven Cognitive Dysfunction. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031182

BibTeX
@article{Ayyubova2026,
  author = {Ayyubova, Gunel and Huseynova, Shahla and Mustafayeva, Nigar and Yildirim, Leyla and Ismayilova, Seher and Gasimova, Tarana and Aliyeva, Sabina},
  title = {Mesenchymal Stem Cell Therapy Modulates Peripheral–Central Immune Interactions and Attenuates Neuroinflammation-Driven Cognitive Dysfunction},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27031182}
}
Kostenlos starten →